Non-substantive Change Request Memo

“Research and Evaluation Survey for the Public Education Campaign on Tobacco among LGBT Young Adults (RESPECT)”

(OMB Control Number 0910-0808)

Change Request (83-C)

January 21, 2021

The Food and Drug Administration is submitting this nonmaterial/non-substantive change request (83-C) to incorporate minor modifications to the study documents for the Research and Evaluation Survey for the Public Education Campaign on Tobacco among LGBT Young Adults (RESPECT).

This change request is to revise the data collection documents for the additional follow-up waves of data collection (follow-up surveys 2-3) for RESPECT, the first of which will begin in March 2017. The follow up data collection will involve re-contacting respondents from previous waves (i.e., longitudinal participants) and recruiting new respondents (i.e., cross-sectional participants) to offset loss to follow-up.

In conversations with OMB in the past, we noted that we expected to have non-substantive changes to our instruments based on the development/changes to the campaign creative. OMB provided concurrence to submit this change.

Details of the changes are included in the table below:

Att #	Documents (tracked changes)	Edits
0	Supporting Statement Part A	Added procedures to prevent fraudulent cases and duplicate or poor quality surveys
0	Supporting Statement Part B	Added sampling quotas
2	Follow Up Instrument	Deleted low priority questions Updated/added campaign videos/radio ads/images Updated questions for clarity/consistency.
2a	Rational for Item Changes to Follow up Instrument FU2 (no tracked changes)	--
5	Screener Informed Consent	Added wording about protecting privacy of data Revised wording of screener for social media respondents
6	Web Survey Informed Consent	Changed age eligibility and verbiage
8	Script for Recruiting Intercept Participants	Updated incentive amounts to include early bird premium
12	Social Media Recruitment Advertisement (no tracked changes version due to file size)	Updated with new images
13	Screener with Informed Consent For Longitudinal Participants	Slightly revised wording of screener for longitudinal respondents and changed age eligibility from 18 – 24 years to 18 – 26 years